These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27790199)

  • 1. Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate
    Hu Q; Peng H; Rao X
    Front Microbiol; 2016; 7():1601. PubMed ID: 27790199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstruction of the Vancomycin-Susceptible
    Peng H; Rao Y; Yuan W; Zheng Y; Shang W; Hu Z; Yang Y; Tan L; Xiong K; Li S; Zhu J; Hu X; Hu Q; Rao X
    Front Microbiol; 2018; 9():2955. PubMed ID: 30546356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP; Peleg AY; Stinear TP
    Infect Genet Evol; 2014 Jan; 21():575-82. PubMed ID: 23567819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.
    Baseri N; Najar-Peerayeh S; Bakhshi B
    Infect Genet Evol; 2021 Jan; 87():104628. PubMed ID: 33171303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.
    Zhu J; Liu B; Shu X; Sun B
    Int J Med Microbiol; 2021 Feb; 311(2):151473. PubMed ID: 33445057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.
    Alam MT; Petit RA; Crispell EK; Thornton TA; Conneely KN; Jiang Y; Satola SW; Read TD
    Genome Biol Evol; 2014 Apr; 6(5):1174-85. PubMed ID: 24787619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ; Lin MH; Shu JC; Lu JJ
    J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive
    Jin Y; Yu X; Zhang S; Kong X; Chen W; Luo Q; Zheng B; Xiao Y
    Front Microbiol; 2020; 11():596942. PubMed ID: 33193280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials.
    Nguyen A; Roy JJS; Kim JH; Yun KH; Lee W; Kim KK; Kim T; Chaurasia AK
    J Microbiol; 2024 May; ():. PubMed ID: 38814539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
    Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
    Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus.
    Sirichoat A; Wongthong S; Kanyota R; Tavichakorntrakool R; Chanawong A; Welbat JU; Lulitanond A
    Jundishapur J Microbiol; 2016 Jan; 9(1):e26069. PubMed ID: 27099678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IS
    Kuroda M; Sekizuka T; Matsui H; Ohsuga J; Ohshima T; Hanaki H
    Front Microbiol; 2019; 10():1882. PubMed ID: 31474962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro.
    Xu J; Pang L; Ma XX; Hu J; Tian Y; Yang YL; Sun DD
    Open Med (Wars); 2018; 13():475-486. PubMed ID: 30426085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels.
    Sirichoat A; Lulitanond A; Kanlaya R; Tavichakorntrakool R; Chanawong A; Wongthong S; Thongboonkerd V
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):340-344. PubMed ID: 27717648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of extracellular polysaccharide and biofilm under different oxygen conditions by clinical isolates of Staphylococcus aureus non-susceptible to glycopeptides.
    Szymanek-Majchrzak K; Wodzyńska S; Młynarczyk A; Młynarczyk G
    Przegl Epidemiol; 2018; 72(4):487-498. PubMed ID: 30810004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Draft Genome Sequences of Vancomycin-Intermediate Staphylococcus aureus Strains in South Korea.
    Kim JW; Yoo JI; Kang GS; Lee YS; Yu JY; Park C; Kim IH
    Genome Announc; 2016 Jun; 4(3):. PubMed ID: 27313284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-intermediate resistance in Staphylococcus aureus.
    Hiramatsu K; Kayayama Y; Matsuo M; Aiba Y; Saito M; Hishinuma T; Iwamoto A
    J Glob Antimicrob Resist; 2014 Dec; 2(4):213-224. PubMed ID: 27873679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.